Skip links
Companies
› Sweden › SynAct Pharma AB
Company registry profile
SynAct Pharma AB logo

SynAct Pharma AB

Private limited company (Ltd.) Active

in

From the registry

Registration details

Registration No.
5590584826
Incorporation Date
Not disclosed
Address
Lund, Sweden
Website
www.synactpharma.com/
Status
Active
Country
Sweden
Source: Swedish Companies Registration Office (Bolagsverket)Registry coverage
Registry summary

Company overview

SynAct Pharma AB is a Private limited company (Ltd.) registered in Sweden under 5590584826, and its current status with Swedish Companies Registration Office (Bolagsverket) is active. Its registered address on file is Lund, Sweden. 1 shareholder is on record for SynAct Pharma AB, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Swedish Companies Registration Office (Bolagsverket) and was last updated on 28 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Swedish Companies Registration Office (Bolagsverket).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

Shareholders of SynAct Pharma AB

One shareholder is currently on record for SynAct Pharma AB, filed with Swedish Companies Registration Office (Bolagsverket). The largest of these is iShares International Small-Cap Equity Factor ETF, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
iShares International Small-Cap Equity Factor ETF 100% Swedish Companies Registration Office (Bolagsverket)

Officers

5

Directors and officers of SynAct Pharma AB

The Chief Executive Officer of SynAct Pharma AB currently on record is Jeppe Ovli Ovlesen Ee, Mba; five officers are currently on record for SynAct Pharma AB, filed with Swedish Companies Registration Office (Bolagsverket). Management authority at SynAct Pharma AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 6 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

JO
Jeppe Ovli Ovlesen Ee, Mba ACTIVE

Residence
🇸🇪 Sweden
Occupation
Chief Executive Officer

JK
James Knight M.b.a. ACTIVE

Residence
🇸🇪 Sweden
Occupation
Chief Business Officer

KH
Kristen Harting M.d. ACTIVE

Residence
🇸🇪 Sweden
Occupation
Chief Medical Officer

TB
Thomas Boesen Ph.d. ACTIVE

Residence
🇸🇪 Sweden
Occupation
Chief Operating Officer

MB
Mads Bjerregaard ACTIVE

Residence
🇸🇪 Sweden
Occupation
Chief Business Officer

Group Structure

Group structure of SynAct Pharma AB

SynAct Pharma AB has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 3 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • TXP Pharma AG (Switzerland)
  • Synact Pharma ApS (Denmark)

Data availability

Those 2 subsidiaries span Sweden, Switzerland, Denmark jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Top of recorded group
SynAct Pharma AB
Sweden
TXP Pharma AG
SwitzerlandCH CHE-271.053.235

Synact Pharma ApS
DenmarkDK 34459975

Registry questions

Frequently asked questions

Who owns SynAct Pharma AB?

One shareholder is currently on record for SynAct Pharma AB, filed with Swedish Companies Registration Office (Bolagsverket). The largest of these is iShares International Small-Cap Equity Factor ETF, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is SynAct Pharma AB's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for SynAct Pharma AB is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does SynAct Pharma AB have on record?

1 shareholder is shown on record for SynAct Pharma AB.

What is SynAct Pharma AB's company registration number?

SynAct Pharma AB's registration number is 5590584826, filed with Swedish Companies Registration Office (Bolagsverket) in Sweden. Its current status on the register is active.

Is SynAct Pharma AB still an active company?

SynAct Pharma AB's status on Swedish Companies Registration Office (Bolagsverket) is listed as active.

What is SynAct Pharma AB's registered address?

The registered address on file for SynAct Pharma AB is Lund, Sweden.

What legal structure is SynAct Pharma AB registered as?

SynAct Pharma AB is registered as a Private limited company (Ltd.) in Sweden.

Who are the officers/directors of SynAct Pharma AB?

The Chief Executive Officer of SynAct Pharma AB currently on record is Jeppe Ovli Ovlesen Ee, Mba; five officers are currently on record for SynAct Pharma AB, filed with Swedish Companies Registration Office (Bolagsverket). Management authority at SynAct Pharma AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does SynAct Pharma AB have a parent company or subsidiaries?

SynAct Pharma AB has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 3 jurisdictions. Those 2 subsidiaries span Sweden, Switzerland, Denmark jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Other companies in Sweden

All companies in Sweden

This website uses cookies to improve your web experience.